Gromeier et al. replaced the viral internal ribosome entry site (IRES) with an IRES of the related human rhinovirus type 2 (HRV2) to target glioblastoma multiforme (GBM), since the receptor of poliovirus CD155 is overexpressed on glioma cells.68 The gene discussed is PVR; the disease is glioblastoma.